Gynecological Devices Market Size, Share, and Analysis, By Device Type (Endoscopy Devices, Endometrial Ablation Devices, Fluid Management Systems, Female Sterilization, and Contraceptive Devices, Hand Instruments, and Diagnostic Imaging Systems), By End-user (Hospitals & ASCs, Diagnostic Centers, and Others) and Regional Forecast, 2024-2032

Gynecology is the physiological study that includes health issues related to women reproductive system such as uterus and ovaries. Gynecological devices includes equipment used in the diagnosis and treatment of disease associated with the women’s reproductive system. It includes devices for contraception, endoscopy, and diagnostic imaging.

Factors such as growing women population, increasing prevalence of gynecological disorders, and rising awareness about health benefits related to early diagnosis and treatment of the gynecological disorders are expected to fuel the market growth.

• For instance, as per the statistics by World Health organization, in 2020, around 604,000 new cases of cervical cancer were registered, making it fourth most common type of cancer in women globally.

Moreover, the increasing adoption of gynecological procedures such as contraception, and laparoscopy, among others is estimated to fuel the demand for gynecological devices during the forecast period.

• For instance, according to the National Center for Health Statistics, in the U.S., cesarean deliveries accounted for 31.8% of the total deliveries in 2020 when compared with vaginal deliveries.

Furthermore, the government in many countries through its programs has also increased focus on creating awareness regarding women health. This factor is also expected to further fuel the global gynecological devices market growth during the forecast period.

• For instance, in January 2022, Center for Devices and Radiological Health (CDRH) as a part of the U.S. Food and Drug Administration (FDA) announced the Health of Women Program Strategic Plan. The objective of this plan is to protect and promote women health, strengthen the regulatory science, and identify as well as address current and emerging issues in medical device research and regulation for the health of all women.

Impact of COVID-19 on the Gynecological Devices Market

The COVID-19 had a negative impact on the global gynecological devices market. This was due to the lockdown restrictions and postponement of the non-emergency procedures during the pandemic. Moreover, the women population delayed the diagnosis of gynecological disorders during the pandemic in order to prevent person to person contact.

Furthermore, reallocation of resources and an increase in hospital beds and ITU capacity for COVID-19 patients led to the postponement and cancellation of the elective non-urgent procedures. As a result patients suffering from gynecological disorders were not able to get the diagnosis and treatment as it was available before 2020. Moreover,

• For instance, as per the data by OECD, 35,414 hysterectomy procedures were conducted in Canada in 2020 experiencing a decline of -15.1% from the prior year.

The market is projected to take a significant time to recover completely from the disruptions caused by COVID-19 pandemic.

Key Insights

The report will cover the following key insights:

• Prevalence of Key Gynecological Diseases - by Key Countries/Regions.


• Number of Key Gynecological Procedures, by Key Countries/Regions.


• New Product Launches.


• Key Industry Developments (Mergers, Acquisitions, Collaborations, etc.).


• Impact of COVID-19 on the Market.

Analysis by Device Type

Endometrial ablation devices accounts for the significant proportion of the global gynecological devices market and is expected to grow at a lucrative CAGR due to the rising burden of endometrial cancer and the growing adoption of these devices due to their ease of use and convenience.

• For instance, according to the World Cancer Research Fund International report 2020, endometrial cancer was the sixth most common cancer in women.


• As per the same statistics, in 2020, there were more than 417,000 new cases of endometrial cancer.

Regional Analysis

North America accounts for the largest share of the global gynecological devices market. The major factor responsible for North America’s largest share in the market is the increasing cases of gynecological cancer in the countries such as the U.S. and Canada.

• According to the Canadian Cancer Society statistics, in 2022, an estimated 8,100 Canadian women are likely to be diagnosed with uterine cancer.

The rising incidences of such gynecological disorders has increased awareness among the women regarding the diagnosis and treatment of various tpes of gynecological disorders.

Key Players Covered

The report will include the profiles of key players such as Medtronic, CooperSurgical Inc., Richard Wolf GmbH, Olympus Corporation, Hologic, Inc. , Boston Scientific Corporation, Stryker, Ethicon (Johnson & Johnson), Meril Life Sciences Pvt. Ltd. and others.

Segmentation

Key Industry Developments

• In September 2022, Olympus Corporation announced the launch of the Guardenia Contained Extraction System by expanding its product portfolio for gynecological procedures.


• In July 2022, GenWork announced its partnership with Medtronic to improve the treatment procedures for inauterine disorders.


• In June 2022, UroViu Corp announced the launch of new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform.